Abstract
Facing the contemporaneous changes which have intensified the market competition, survival strategies are essential for the company sustainability, such as the protection of intangible assets through the patents, which confer several advantages. In the pharmaceutical industry, where the products are result from expensive processes, the patents have become an important incentive. This article has undertaken a systematic analysis of patenting in the Brazilian pharmaceutical industry, evaluating the patents indicators of the major pharmaceutical companies in Brazil in order to categorize their strategies. The results indicated the leadership of Aché in patent applications, an extremely small number of concessions, characterizing the majority of the deposits as Invention Patents, and the lack of partnerships with universities and /or foundations for research support. The EMS and Eurofarma companies have presented analytical strategic performance, the União Química, defender, and Aché and Hypermarcas, prospector performance.
Highlights
The fierce competition that constitutes the current business environment requires constant training and continuous improvement of the companies that aim to survive and prosper (Piscopo, 2010)
A research was conducted at the database of the Instituto Nacional de Propriedade Industrial (INPI) in May 2015, about the application for patent deposits corresponding to the identified companies, and it was used for the data collection, the name of each of the selected companies with the search term “Name of Depositor” by advanced search
The exclusive choice of the INPI database occurred because the object of the search is related only to the reality of patenting of the pharmaceutical industry in Brazil and because the institute is responsible for the management of the Brazilian system of concession and guarantee of the intellectual property rights
Summary
The fierce competition that constitutes the current business environment requires constant training and continuous improvement of the companies that aim to survive and prosper (Piscopo, 2010). At this juncture, the legally protected intellectual property (IP) has become an important asset for the competitiveness of businesses of the companies which aspire to maximize the value of their intangible assets (Jungmann and Bonetti, 2010). The data present in the patent can be turned into strategic indicators for the competitive analysis of the characteristics of technologies, opportunities, and threats, of the organizations and relevant researchers, in addition to other associated aspects (Scopel et al, 2013).
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
